ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Stopped early

Conditions studied: Bladder Cancer

In brief

Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting

Key facts

Study ID
NCT06026332
Run by
Ferring Pharmaceuticals
People needed
202
Starts
2023-09-15
Expected to finish
2026-01-15
Last updated by the study team
2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.